Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Experience and challenges from clinical trials with malaria vaccines in Africa

Type de record:

paper
Créateur:
MwaOguMsaMze
Éditeur:
Bio
Hôte:avatar

Visit

doi.orgedoc.unibas.ch

Similaires

Communities and Clinical Trials: A Case Study from the RTS,S Malaria Vaccine Trials in Eastern AfricaChallenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 StudyGeographical Scope of Randomized Clinical Trials From AfricaCancer Clinical Trials AfricaBuilding a national framework for multicentre research and clinical trials: experience from the Nigeria Implementation Science AllianceDefining surrogate endpoints for clinical trials in severe Falciparum malaria.

Communities and Clinical Trials: A Case Study from the RTS,S Malaria Vaccine Trials in Eastern Africa

When clinical trials enter human communities, two complex systems merge—creating challenges for the

Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study

The purpose of this article is to describe lessons from the first lymphoma clinical trial conducted

Geographical Scope of Randomized Clinical Trials From Africa

Objective Africa ranks second of the 7 continents in population and geographical area. Reports of re

Cancer Clinical Trials Africa

⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suita

Building a national framework for multicentre research and clinical trials: experience from the Nigeria Implementation Science Alliance

There is limited capacity and infrastructure in sub-Saharan Africa to conduct clinical trials for th

Defining surrogate endpoints for clinical trials in severe Falciparum malaria.

Objective

To validate surrogate endpoints for mortality in intervention studies in pati